For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
23
views
1
references
 Top references
cited by
1
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      1
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Corrigendum to “Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma”

      correction

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In the article titled “Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma” [1], affiliation number one was given incorrectly. The corrected affiliation is shown above.

          Related collections

          Most cited references1

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma

          Xiao-Meng Dai, Tao Huang, Sheng-Li Yang … (2017)
          Accumulating evidence suggests that the tumor microenvironment has a profound influence on tumor initiation and progression, opening a new avenue for studying tumor biology. Nonetheless, the prognostic values of the peritumoral expression of EpCAM and CD13 remain to be elucidated in hepatocellular carcinoma (HCC) patients. In this study, the expression of EpCAM and CD13 was assessed by immunohistochemistry in peritumoral liver hepatocytes from 106 hepatitis B virus- (HBV-) related HCC patients who had undergone curative hepatectomy. The peritumoral EpCAM-positive group had a significantly worse overall survival (OS) (p = 0.003) and recurrence-free survival (RFS) (p = 0.022) compared to the negative group. Peritumoral CD13-positive patients were also associated with poor OS (p = 0.038), while not significantly associated with RFS. The adjusted multivariate COX proportional hazard regression analysis suggested that only the positive expression of peritumoral EpCAM precisely predicted poor OS. Being peritumoral EpCAM positive was also significantly associated with a larger tumor size, liver cirrhosis, and more frequent vascular invasion; however, no statistically significant association was observed between CD13 and any clinicopathological features. Taken together, peritumoral EpCAM and CD13 expression was associated with a poor prognosis, but EpCAM may be a better prognostic marker than CD13 in HBV-related HCC patients. In the future, peritumoral EpCAM could be a good target for adjuvant therapy after curative hepatectomy.
          Article 0 comments Cited 10 times – based on 0 reviews     Review now
            Bookmark
            All references

            Author and article information

            Contributors
            Sheng-Li Yang:
            ORCID: http://orcid.org/0000-0002-2068-7618
            Tao Zhang:
            ORCID: http://orcid.org/0000-0002-0290-7015
            Journal
            Journal ID (nlm-ta): Dis Markers
            Journal ID (iso-abbrev): Dis. Markers
            Journal ID (publisher-id): DM
            Title: Disease Markers
            Publisher: Hindawi
            ISSN (Print): 0278-0240
            ISSN (Electronic): 1875-8630
            Publication date (Print): 2017
            Publication date (Electronic): 20 September 2017
            Volume: 2017
            Electronic Location Identifier: 3765279
            Affiliations
            1Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
            2Department of Pediatrics, Tianyou Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430064, China
            3Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong
            Author information
            http://orcid.org/0000-0003-0673-1886
            http://orcid.org/0000-0002-2068-7618
            http://orcid.org/0000-0002-0290-7015
            Article
            DOI: 10.1155/2017/3765279
            PMC ID: 5632465
            SO-VID: 3d0bc362-16d3-4c69-971c-0dd5f09d439b
            Copyright © Copyright © 2017 Xiao-Meng Dai et al.
            License:

            This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

            History
            Date received : 11 July 2017
            Date accepted : 6 August 2017
            Related
            Categories
            Subject: Corrigendum

            Data availability:

            Comments

            Comment on this article